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Effects of angiotensin II blockade in the canine puppy under different
salt-intake. The objective of this study was to investigate the relation-
ship between the high activity of the renin-angiotensin-aldosterone
system (RAAS) and the control of blood pressure and aldosterone in the
canine puppy. The effect of the angiotensin II analog saralasin on
arterial pressure (MAP), plasma renin activity (PRA), plasma renin
concentration (PRC), and aldosterone (PA) was studied in unanesthet-
ized normal, salt-loaded and salt-depleted puppies aged 9 to 30 days.
Salt-loading was performed by daily intraperitoneal administration of 10
mEq sodium/kg body weight for 5 days and salt-depletion by furose-
mide injections. Saralasin infusion, 6 sg/kg/min, during 60 mm signifi-
cantly decreased MAP and increased PRC not only in salt-depleted
puppies, as has been observed in adult salt-depleted dogs, but also in
normal puppies (mean fall, 6.6 mm Hg). Although any developmental
changes in the RAAS and MAP and in their relationship could not be
ascertained, the fall in MAP during saralasin in normal puppies was
significantly correlated to presaralasin renin values (r = 0.76, P <0.01,N = 11). PA did not change in both groups of puppies. In salt-loaded
puppies saralasin caused no change of MAP, PRC, and PA. We
conclude that the high renin levels at young age contribute to the basal
arterial pressure in puppies.
Effets du blocage de l'angiotensine II chez Ic chiot soumis a différents
apports fodés. L'objectif de cette étude a été d'dtudier Ia relation entre
l'activité élevée du système rénine-angiotensine-aldostérone (RAAS) et
le contrôle de Ia pression sanguine et de l'aldostérone chez le chiot.
L'effet de Ia saralasine, un analogue de l'angiotensine II sur la pression
artérielle (MAP), l'activité refine de (PRA), la concentration de refine
plasmatique (PRC), et l'aldostérone plasmatique (PRA) a été étudié
chez des chiots normaux, éveillës, surcharges on déplétés en sd, âgés
de 9 a 3Ojours. La surcharge saline a été effectuée par administration
tntrapéritonéale quotidienne de 10 mEq de sodium/kg de poids corporel
pendant 5 jours et la déplétion saline par injection de furosémide. Une
perfusion de 6 jsg/kg/min de saralasine pendant 60 mm a significative-
ment diminué MAP, et a augmenté PRC, non seulement chez les chiots
déplétés en sel comme cela a été observe chez des chiens adultes
déplétés en sel, mais aussi chez des chiots normaux (chute moyenne,
6,6 mm Hg). Bien qu'aucune modification dans Ic développement du
RAAS et de MAP et de leur interrelation n'ait pu être montrée, Ia chute
du MAP avec Ia saralasine chez les chiots normaux était significative-
ment corrélée aux valeurs de rénine pré-saralasine (r = 0,76, P < 0,01,N = II). PA n'a change dans aucun des deux groupes de chiots. Chez
les chiots en surcharge saline, Ia saralasine n'a modiflé ni MAP, ni PRC
et ni PA. Nous concluons que les niveaux élevés de rénine a un jeune
age contribuent a Ia pression artérielle de base chez les chiots.
Angiotensin II (All) is known as a potent arteriolar
vasoconstrictor and stimulator of aldosterone secretion. The
All analog l-sarcosine-8-alanine-AII (saralasin) acts as an an-
tagonist for both the pressor and the steroidogenic action of
exogenous All in the adult dog [5}. In the normal adult dog,
however, saralasin failed to reduce arterial pressure or to
influence plasma renin activity (PRA). In contrast, in the acute
and chronic salt-depleted dog with high circulating levels of
renin and plasma aldosterone concentration (PA), All antago-
nists reduced arterial pressure and PA, and further increased
PRA [5-7].
The higher levels of renin and All at a young age could point
to a more important role of the renin-angiotensin system (RAS)
in the maintenance of blood pressure (BP) and in the control of
aldosterone secretion compared to adult dogs. Therefore, a BP
lowering effect and a decrease in aldosterone secretion could be
expected in the normal puppy treated with saralasin.
Although saralasin infusion produced no change in mean
arterial pressure (MAP) in the anesthetized 14- to 25-day-old
puppy on a normal diet [8], studies concerning the physiological
role of the RAAS should be performed in the unanesthetized
state, since anesthesia clearly influences both PRA, PA, and
MAP even in trained dogs [9, 10].
The aim of this study was to determine the effects of All
blockade with saralasin on MAP, PRA, active plasma renin
concentration (PRC), and PA in unanesthetized puppies under
normal, salt-loaded and salt-depleted conditions.
Methods
Puppies. Experiments were performed on unanesthetized
puppies of either sex from purebred beagle strains, ranging in
age from 9 to 30 days and weighing between 460 and 1230 g. The
puppies were obtained from unweaned litters whelped in the
animal quarters. The mothers were fed commercial dog food
(Hope Farms complete dog food D-B, Worden, The Nether-
lands), additional milk, and water ad libitum. The puppies were
allowed free access to their mothers milk but not to other food
In the puppy the activity of the renin-angiotensin-aldosterone
system (RAAS) is elevated compared to the adult dog [1—4].
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Table 1. Experimental procedure
Penoda Control Experimental Recovery
Infusion in inferior Glucose 5% Saralasin 6 g/kg/min Glucose 5%
vena cava 1.2 mI/hr or glucose 5%
Both 0.1 mI/mm
1.2 mi/hr
Arterial sample I, 3 ml
PRA-PRC
PA
SNaSK
SosmHct
II, 2 ml
PRA-PRC
PA
III, 3 ml
PRA-PRC
PA
SNaSK
SosmHct
Abbreviations: PRA, plasma renin activity; PRC, plasma renin concentration; PA, plasma aldosterone concentration; SNa, serum concentration
of sodium; SK, serum concentration of potassium; Sosm, serum osmolality; Hct, hematocrit.
Each period lasted 60 mm.
or water. They were assigned to one of four groups: a salt-
loaded and a salt-depleted group and two control groups.
Salt-loading was performed by daily intraperitoneal administra-
tion of 0.9% saline in a dose of 10 mEq sodium/kg body weight
for 5 days; the last administration was 6 to 8 hr prior to the
experiment. Salt-depletion was induced by daily intramuscular
administration of furosemide 1 mg/kg body weight for 4 days;
the last injection was given 6 to 8 hr prior to the experiment.
The first control group consisted of animals which were only
surgically manipulated; in addition, on a daily basis, the second
control group received an intraperitoneal injection of 5 ml
glucose 5% and should be compared with the salt-loaded group.
Animal preparation. The day before the experimental proce-
dure the puppy was anesthetized with ether. Polyethylene
tubings 50-cm long (PE-50 or 60, Intramedic, Clay-Adams,
Parsippany, New Jersey), were placed in the descending aorta
and the inferior vena cava below the level of the renal arteries
and veins. The catheters were introduced via the femoral
vessels after a small incision in the groin. After filling with a
heparin solution (500 U/mI), they were sealed and tunneled
subcutaneously to the lower part of the upper leg. The wounds
were closed with sutures and the exit wound was covered. The
animal was allowed to awaken and was returned to the litter in
the animal quarters for a recovery period of at least 14 hr prior
to the experiment.
Experimental procedures
All experiments were performed in unanesthetized animals in
a quiet laboratory in either morning or afternoon. No significant
difference in active plasma renin concentration (PRC) has been
observed between morning or afternoon samples [31. During the
experiment the puppies were kept warm and quiet in a supine
posture, on a padded laboratory table. The aorta catheter was
connected to a pressure transducer (Statham P23 Dd, Oxnard,
California) and MAP was recorded continuously on a recorder
(Beckman RP Dynograph, Fullerton, California). The values for
MAP were obtained at 1-mm intervals and averaged for the last
40 mm of each period.
The catheter in the inferior vena cava was connected to a
pump for the infusion of glucose 5% or saralasin. The experi-
mental protocol is schematically summarized in Table 1. Each
of the three periods—control, experimental and recovery—
lasted 60 mm. Glucose 5% was infused at a rate of 1.2 mI/hr
during the control and recovery period. Saralasin at a rate of 6
1rg/kg/min in 0.1 ml/rnin glucose 5% or glucose 5% alone was
administered in the experimental period. At the end of each
period, blood samples were collected from the aorta catheter
and the amount of blood was replaced with an equal amount of
Ringer's solution containing the resuspended packed cells of
the previous sample. At the end of the control period, blood
samples (I) were collected for the determination of plasma renin
activity (PRA), plasma renin concentration (PRC), plasma
aldosterone concentration (PA), serum concentration of sodium
(SNa) and potassium (SK), serum osmolality (Süsm), and
hematocrit. At the end of the experimental period, blood
samples (II) were collected for the determination of PRA, PRC,
and PA, and after the recovery period (III) for the determina-
tion of PRA, PRC, PA, SNa, SK, Sosm, and hematocrit.
To our knowledge, no data on basal values of plasma angio-
tensin II (All) are available in puppies; therefore we performed
an additional experiment in four controls of 10 to 22 days of age.
After a 60-mm infusion of glucose 5% at a rate of 1.2 mI/hr in
these puppies, plasma All was measured.
Analytical methods
Blood samples were collected into ice-cooled tubes. The
tubes for the determination of All contained 0.125 M EDTA and
0.025 M 0-phenanthroline in distilled water (0.25 ml/7 ml blood)
as inhibitors. The tubes for the determination of PRA, PRC, and
PA contained 10 mg potassium EDTA. Plasma was immediately
separated in a refrigerated centrifuge, quickly frozen, and kept
stored at —20°C until time of assay. Flematocrit, Ssm, 5Na, and
SK were determined with standard laboratory tests. PRA was
measured with a commercial kit (Clinical Assays) in which the
enzymatical step was scaled down to one third of the volumes
prescribed by the manufacturer. Briefly, the sample was in-
cubated at pH 6.0 and 37°C in the presence of angiotensinase
inhibitors, and the angiotensin I (Al) generated was measured
by radioimmunoassay. For the PRC assay excess of homolo-
gous dog renin substrate, obtained 48 hr after bilateral nephrec-
tomy, was added to the plasma sample. All samples were
corrected for the renin still present in the substrate pooi. Plasma
aldosterone concentration was measured by a direct radio-
immunoassay [11]. Plasma All concentration was measured as
previously described [12]. Sensitivity of the assay for PRA was
0.15 ng, Al/ml/hr; for PRC 5, ng AI/ml/hr; for PA, 5 ng/dl; for
All, 4 pg/mI. The within-run coefficient of variation for the PRA
assay at a level less than 10 ng Al/mi/hr was 5%, and at a level
15
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greater than 10 ng AI/ml/hr, it was 4%; for PA, it was 10% at a
level less than 15 ng/dl, and 3.5% at a level greater than 15 ng/dl;
for All, it was 6.6% at a level of 43 pg/mI. The within-run
coefficient of variation for the PRC assay was 3.5% at a level of
greater than 40 ng AI/ml/hr; at a level less than 40 ng Al/mi/hr
the SD was 1.0.
Statistical analysis
To obtain the Gaussian distribution, the original data of the
RAAS were statistically analyzed after logarithmic transforma-
tion [13]. The mean and the one-SD range were then trans-
formed back to the model median (equal to the geometric mean)
and the one-sr range of the raw data. Stiistical analysis of the
other measurements—MAP, SNa, SK, Ssm, hematocrit, and
age—was performed on the original data.
Differences between animal groups were tested with one-way
analysis of variance. If there was a significant difference in case
of more than two groups, the simultaneous method of Scheffb
indicated which of the groups differed from the others.
The influence of glucose or of saralasin infusion on MAP was
evaluated with a mixed two-way analysis of variance with
interaction. The influence on blood chemistry and hormone
levels was evaluated with the Hotelling T2 test [14], a multivari-
ate generalization of the Student's paired t test. Significant
differences between sampling times were evaluated further with
simultaneous methods.
Significance was accepted at a P < 0.05 level.
Results
Basal values in puppies
Control puppies. Basal values for PRA, PRC, PA, SNa, SK,
S0sm, hematocrit, and MAP were not significantly different
between the two control groups and were therefore combined.
Figure 1 A and B depict PRA and PA values at different ages in
the control puppies. No correlation between PRA and age
existed. PA was positively but weakly correlated with age (r =
0.54, P = 0.03, N = 17). As can be seen from the figure, this
correlation, however, depends on two points recorded in pup-
pies of 20 and 22 days of age. In addition, the correlation also
seems to depend on the combination of values in different
litters, since within litters no obvious relation can be seen. PRA
levels in the puppies were considerably higher (P < 0.01) than
in adult dogs (median, 1.4 ng AI/ml/hr; range, 0.7 to 3.4; N =
10). In the four additional experiments where only glucose was
infused, base line All levels in the puppies (median value, 50.1
pg/ml; range, 22 to 114) were higher (P < 0.01) than in adult
dogs (median value, 9.2 pg/ml; range, 4 to 20, N = 10). In
contrast, PA levels in the puppies ranged from 7 to 51 ng/dl and
were not different (P > 0.10) from the values in adult dogs
(median, 19 ng/dl; range, 15 to 27; N = 10).
In 9- to 28-day-old control puppies, no correlation could
further be established between age and MAP; the latter was also
not correlated with PRA. PA was only weakly correlated with
PRA (r = 0.45, P = 0.07) and PRC (r = 0.60, P = 0.01), but not
with SNa or 5K The overall correlation between PRA and PA
seems to depend on the combination of litters, since this
correlation did not exist in littermates.
Influence of different salt-intakes. The basal values of all
variables in the different groups of puppies are summarized in
Tables 2 and 3.
Salt-loading resulted in significantly lower values for PRA,
PRC, and PA (Table 3) compared to control salt-intake, but
values for PRA and PRC as low as in adult dogs were not
obtained. Salt-loading had no significant influence on the mean
plasma levels of 5Na, 5K Süsm, and hematocrit (Table 2). As in
the case of normal puppies, PA levels in salt-loaded animals
were not different from those in adult dogs.
Salt-depleted puppies had significantly higher PRA and PRC
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Fig. 1. A Plasma renin activity (PRA) and B plasma aldosterone concentration (PA) in unanesthetized normal puppies. The symbols designate
different litters.
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Control puppies
Salt-loaded
puppies (10)
Mean SD
Salt-depleted
puppies (4)
Mean SDN Mean SD
Age, days 17 17.0 5.3 23.5c 7.0 19.8 3.4
MAP, mm Hg 17 64.1 14.1 62.1 7.5 75.0 17.7
5Na, mmoles/liter 13 135.7 2.6 136.9 2.4 132.3L 3.0
5K mmoles/iiter 13 3.78 0.39 3.63 0.38 3.15" 0.47
5Osm, Osm/kg 13 282.9 7.9 282.8 6.4 283.3 6.7
Hct, liters/liter 13 0.282 0.038 0.258 0.031 0.253 0.036
Abbreviations: MAP, mean arterial pressure; see Table I
a Statistically significant differences either between control puppies and salt-loaded puppies or between control and salt-depleted puppies are
indicated; the number of puppies are within parentheses.
0.01 < P < 0.05.
a P < 0.01.
Table 3. Model medians and one-sD ranges (between brackets) for
basal values of plasma renin activity (PRA) and active plasma renin
concentration (PRC), and plasma aldosterone concentration (PA) in
different groups of puppiesa
Control
puppies(N = 17)
Salt-loaded
puppies(N = 10)
Salt-depleted
puppies(N = 4)
Age, days 17.0
(11.7 to 22.3)
23.5"
(16.5 to 30.5)
19.8
(16.4 to 23.2)
PRA, ng Al/mI/hr 9.66
(5.53 to 16.90)
3.65"
(2.22 to 6.01)
47.06L
(27.45 to 80.68)
PRC,ng Al/mi/hr
PA, ng/dl
12.1
(6.7 to 21.9)
19.2
(10.8 to 34.1)
5.2"
(3.1 to 8.8)
l5.9b
(12.1 to 20.7)
153.8"
(38.8 to 609.8)
44.5
(32.1 to 61.7)
a Statistically significant differences between control puppies and
salt-loaded puppies, or between control and salt-depleted puppies are
indicated.
P < 0.01.
levels than control puppies (Table 3), and lower values of SNa
and SK (Table 2). Median PA (Table 3), although it seemed
higher than in controls, was not statistically different between
control and salt-depleted puppies, probably because of the
small number in the latter group.
The mean MAP was not significantly different between the
three groups of puppies.
Effects ofglucose and saralasin infusion
Mean arterial pressure
Glucose infusion. In the control experiments with glucose
infusion alone (Fig. 2A), the overall MAP did not change
consistently. As can be noted from Figure 3A, seven of the nine
animals responded with a slight increase in BP; two animals
showed a decrease of MAP. During the recovery period, the
MAP remained further unchanged.
Saralasin infusion. In the saralasin experiments in control
puppies (Fig. 2B), the overall MAP decreased significantly with
a mean of 6.6 mm Hg during the infusion and returned toward
the control value during recovery compared to the control
period. The decrease in MAP was significantly correlated with
basal PRC levels (r = 0.76, P < 0.01). Figure 3B summarizes
the individual changes in MAP during and after saralasin
administration. Contrary to the glucose experiments, in these
II animals during saralasin, eight responded with a fall while
only one showed a slight increase in MAP. In two animals the
MAP did not change. Therefore, in contrast with glucose
infusion, saralasin was able to induce a fall in BP. During
recovery, most animals responded with a return toward the
original BP or showed no further change. Compared to the
normal animals, all four salt-depleted puppies showed a more
pronounced reduction of MAP during saralasin infusion (Figs.
2D and 3D), and also an almost complete return of the MAP to
control values during recovery.
On the other hand, the increase of MAP in the salt-loaded
animals (Figs. 2C and 3C) during saralasin, although more than
in the glucose experiments, was not significant.
Plasma renin activity and concentration, plasma aldosterone
The influence of either glucose or saralasin infusion on the
hormonal changes is also shown in Figure 2.
Glucose infusion. In the glucose experiment all changes in
PRA, PRC, and PA were not statistically significant.
Saralasin infusion. Saralasin in the control puppies resulted
in a significant increase in PRA and PRC with a median of 80
and 163%, respectively. Both values returned toward normal
after stopping the saralasin infusion.
In the salt-depleted group the median PRC increased while
the median PRA remained unchanged. The difference between
PRA and PRC in this group depends on substrate limitation in
the PRA assay.
In salt-loaded animals no significant changes in either PRA or
PRC were observed in the experimental period.
In none of the groups did saralasin create a significant change
in PA during the experimental period.
Discussion
As could be expected, the basal levels of PRA, PRC, and All
were higher in unanesthetized puppies than in adult dogs. No
correlation was found between PRA or PRC and age in the
range of 9 to 28 days, which contrasts other reports on dogs
[2—4] and might be due to the wide range of renin values
obtained. It is also possible that the age range in our puppies
was too small or that the results were influenced by differences
between litters. Significant differences in PRC between litters at
each age between 1 day to 3 weeks have been reported.
Table 2. Basal values of MAP, SNa, SK, So,, and Hct in different groups of puppiesa
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Fig. 2. Estimates of and simultaneous 95% confidence intervals for
median absolute or percental changes (A) from base line values of
mean arterial pressure (MAP), plasma renin activity (PRA), active
plasma renin concentration (PRC), and plasma aldosterone concentra-
tion (PA) during (LI) and after (LI) glucose infusion in control puppies,
and during (LI) and after (LII) saralasin infusion in the three different
groups of puppies. P values for changes in MAP (analyzed with a mixed
two-way analysis of variance with interaction) and for changes in PRA,
PRC, and PA (analyzed with Hotelling T2 test) are indicated. The (*)
refers to N = 5 for PRA, PRC, and PA.
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Fig. 3. Absolute changes from base line values of mean arterial
pressure (MAP) during glucose or saralasin infusion in the experimen-
tal period (II) and at the end of the recovery period (III).
PRA is substrate-limited in puppies, as has been reported for
the newborn lamb [15]. The influence of the amount of substrate
on the generation of A! in newborn puppies has been shown by
Drukker [2]. Plasma renin substrate concentrations in puppies
from birth to 3 weeks of age were similar to adult values [2].
The median PA level in the puppies was not different from the
level obtained in adult dogs. A decrease in PA with advancing
age has been reported in humans [16—25] and animal [4, 26—34].
PA values in our adult dogs were higher compared to those
reported previously by other investigators [6, 35].We collected
samples in adult dogs between 8:30 and 9:30 A.M. Posture,
activity, and food intake were not controlled. As the PRA
values in these adult dogs were much lower than in the puppies,
and because the dogs had free access to water, these animals
seemed not to be in a dehydrated state. PA was probably
stimulated by potassium or ACTH.
The lack of a negative correlation between PA and age in our
puppies might be due to the same reasons as mentioned above
for PRA and PRC.
Although salt-loading significantly decreased PRA, values as
low as those in adult dogs were not reached. In addition,
salt-loading resulted also in a lower PA compared to controls.
This confirms the data of John et al [41 and Ito et al [341.
On the other hand, despite the already high baseline RAAS
activity, salt-depletion resulted in a significant further stimula-
tion of PRA and PRC. The higher PA in salt-depleted puppies
compared to the controls did not reach statistical significance,
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However, these observations could not explain the age-related
changes in PRC [31.
Median PRA level in salt-depleted puppies did not increase
with saralasin infusion (Fig. 2D), but after the addition of excess
homologous renin substrate median PRC rose clearly. Maximal
possibly because of the small number. In adult beagle dogs, 2 to
3 years of age, an enhanced adrenocortical response to admin-
istered All has been observed during sodium depletion [36]. On
the other hand, the aldosterone response to actual plasma A!!
concentration was diminished in younger lambs [37]. Finally,
the significantly lower SK in our salt-depleted puppies, caused
by the kaliuretic effect of furosemide, might have counteracted
the stimulatory effect of All on aldosterone secretion.
Variation in salt intake did not significantly alter the basal
MAP in our puppies, which contrasts with results obtained by
Siegel [38] in newborn lambs, where acute and chronic extra-
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cellular volume expansion by salt-loading caused an unex-
pected decrease in MAP. This was associated with an ap-
proximate 70% fall in PRA in chronic salt loading, which is
quite similar with the decrease in PRA noted in our volume-
expanded puppies. Although the explanation for this different
BP behavior must remain speculative, it is clear that the
adaptation of the BP to chronic salt loading in the puppy is
different from the newborn lamb.
Saralasin infusion not only decreased MAP in the salt-
depleted puppy, as is reported for the adult dog [5, 6] but also
in the normal puppy on bitch milk only. Although in the age
range studied neither a correlation between PRA or MAP and
age, nor between PRA and MAP could be established, the fall in
MAP during saralasin infusion was significantly correlated to
presaralasin renin values. The hypotensive action of saralasin
has also been reported in the conscious newborn lamb during
the first 2 weeks of life [15, 38] but was not seen in the
anesthetized 14- to 25-day-old puppy [8]. Anesthesia influences
MAP and PRA [9] and therefore studies concerning the role of
the RAS in the maintenance of BP should be performed in
unanesthetized animals. In 4- to 38-day-old lambs, the ACE
inhibitor captopril also resulted in a significant decrease in MAP
[39]. However, changes in the bradykinin-kinin system may be
induced by converting enzyme blockade with captopril. In any
case, the decline in arterial pressure in response to saralasin or
captopril in young animals suggests that the increased activity
of the RAS at young age contributes to the basal BP.
Similar to adult dogs [5, 6], no decrease in MAP by saralasin
in salt-loaded puppies was noted, which confirms the results
obtained by Siegel [38] in stlt-loaded lambs.
Normal and salt-depleted puppies responded to saralasin
infusion with a marked increment in PRC (Fig. 2 B and D), as
was also reported in the newborn lamb [15]. This might be the
result of either a blockade of the short-loop negative feedback
of angiotensin on the juxtaglomerular cells, the fall in arterial
pressure, or a combination of both mechanisms. However, in a
minority of our puppies the rise in PRA and PRC was dissoci-
ated from a fall in BP. This observation suggests that an
activation of the RAS after All blockade in the young animal is
not only due to a change in BP. Salt-loaded puppies with
suppressed renin showed no increment in PRA and PRC, and
therefore responded similarly to saralasin as conscious normal
adult dogs [6].
On the other hand, PA remained unchanged during saralasin
infusion in control, salt-loaded as well as in salt-depleted
puppies. It should be noted that saralasin has been reported to
cause a fall in PA in the salt-depleted adult dog [6].
Saralasin is known to have partial agonistic effects on arterial
pressure and aldosterone production, especially during high salt
intake and at low levels of PRA. We were unable to demon-
strate both responses in the salt-loaded puppies.
In summary, the importance of the increased activity of the
RAS in the control of basal BP was shown by the hypotensive
action of saralasin, a potent All antagonist. Variations in salt
intake dramatically influenced both the response of BP and the
levels of PRA and PRC. It is therefore concluded that the
enhanced activity of the RAS in the young animal significantly
contributes to the maintenance of normal BP. It must be
recognized that other vasoactive or neurogenic factors may
play a role in the regulation of the BP.
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